Metastatic Chromophobe Renal Cell Carcinoma

specific

A chromophobe renal cell carcinoma that has spread from the original site of growth to another anatomic site.

37

Centers

37

Active Trials

Cancer Funding

Top Centers for Metastatic Chromophobe Renal Cell Carcinoma(37)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
51.4
2
NCI Comprehensive
Active Research Program
51.4
3
NCI Comprehensive
Active Research Program
51.4
4
NCI Comprehensive
Active Research Program
51.4
5
NCI Comprehensive
Active Research Program
51.4
6
NCI Comprehensive
Active Research Program
51.4
7
NCI Comprehensive
Active Research Program
51.4
8
NCI Comprehensive
Active Research Program
51.4
9
NCI Comprehensive
Active Research Program
51.4
10
NCI Comprehensive
Active Research Program
51.4
11
NCI Comprehensive
Active Research Program
51.4
12
NCI Comprehensive
Active Research Program
51.4
13
NCI Comprehensive
Active Research Program
51.4
1451.4
15
NCI Comprehensive
Active Research Program
51.4
16
NCI Comprehensive
Active Research Program
51.4
17
NCI Comprehensive
Active Research Program
51.4
18
NCI Comprehensive
Active Research Program
51.4
19
NCI Comprehensive
Active Research Program
51.4
20
NCI Clinical
Active Research Program
51.4
21
NCI Comprehensive
Active Research Program
51.4
22
NCI Comprehensive
Active Research Program
51.4
23
NCI Comprehensive
Active Research Program
51.4
24
NCI Clinical
Active Research Program
51.4
25
NCI Comprehensive
Active Research Program
51.4
26
Active Research Program
51.4
27
Active Research Program
51.4
28
Active Research Program
51.4
29
Active Research Program
51.4
30
Active Research Program
51.4
31
Active Research Program
51.4
32
Active Research Program
51.4
3351.4
34
Active Research Program
51.4
35
Active Research Program
51.4
36
Active Research Program
51.4
37
Active Research Program
51.4

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →